Enter to open, tab to navigate, enter to select
AbbVie Inc. and Cerevel Therapeutics Holdings, Inc. merger
| December 06, 2023 • Public Merger Agreements • $8.7 billion (equity value disclosed by the parties). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.